Printer Friendly
The Free Library
19,585,452 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Altair Nanotechnologies Revenues More Than Double in Second Quarter; Altairnano Year-on-Year Revenues Grow by More Than 100 Percent; Quarter-on-Quarter Revenues Up 94 Percent.


RENO Reno (rē`nō), city (1990 pop. 133,850), seat of Washoe co., W Nev., on the Truckee River; inc. 1903. Tourism has been the major industry since gambling was legalized in Nevada in 1931. , Nev. -- Altair Altair (ăltä`ĭr), brightest star in the constellation Aquila (Eagle); Bayer designation α Aquilae; 1992 position R.A. 19h50.5m, Dec. +8°51'. Its apparent magnitude is 0.  Nanotechnologies Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:ALTI Alti is a fictional character in the television series . She is portrayed by Claire Stansfield. Overview
Alti is a Northern Amazon shaman driven out of her Siberian tribe by Queen Cyane, because of her hunger for power.
), a leading provider of advanced nanomaterials Nanomaterials is the study of how materials behave when their dimensions are reduced to the nanoscale. It can also refer to the materials themselves that are used in nanotechnology.  technology for use in energy, pharmaceutical, life sciences and industrial applications, today reported its revenues more than doubled in the second quarter, ended June June: see month.  30, 2006, compared to the second quarter of 2005.

In the wake of escalating customer interest in the unique properties of Altairnano's patented nanomaterials, the company reported second quarter revenues of $1.057 million, up from $502,881 for the second quarter of 2005. In quarter-on-quarter growth, Altairnano's Q2 revenues grew 94 percent, up from $545,000 in Q1 of 2006.

The Company's net loss for the second quarter was $3.78 million, or $0.06 per share, versus $1.91 million, $0.03 per share, for the second quarter of fiscal 2005.

"Batteries, battery packs and battery systems are a major driver for our business. As a result, we are continuing to expand our investment in our Advanced Materials Advanced Materials is a leading peer-reviewed materials science journal published every two weeks. Advanced Materials includes Communications, Reviews, and Feature Articles from the cutting edge of materials science, including topics in chemistry, physics,  and Power Systems (AMPS) business unit, which has accounted for a significant portion of our increased expenses this quarter," Altairnano AltairNano is a Reno, Nevada-based research company that develops nanotechnology-based solutions for energy storage and the life sciences. In particular, the company is well known for its "NanoSafe" lithium-ion battery technology that is used in battery-electric vehicles.  Chief Financial Officer Edward Dickinson This article is about the Massachusetts representative. For the Ohio representative, see Edward F. Dickinson.
Edward Dickinson (January 1 1803 - June 16 1874) was a Massachusetts politician.
 said. "However, we believe strongly these strategic investments in research and development and marketing in AMPS, and others we are making in the Company, will produce strong returns."

Altairnano's balance sheet at the end of the second quarter was strong, with cash and short term investments totaling $14.4 million. The Company's debt remains at $2.4 million from a mortgage obligation to acquire the company's 80,000 square feet of offices, laboratories and semi-works facilities in Reno, Nevada Nevada (nəvăd`ə, –vä–), far western state of the United States. It is bordered by Utah (E), Arizona (SE), California (SW, W), and Oregon and Idaho (N). .

"The second quarter was a period of continued commercialization development for Altair Nanotechnologies, and in our power systems business set the stage for the first order for electric vehicle batteries which we received in July July: see month. , 2006. We believe the future will be marked by still greater demand for our innovative nanomaterials coupled with a broad range of expanding commercial applications," said Altair Nanotechnologies Inc. President and Chief Executive Officer Alan A`lan´   

n. 1. A wolfhound.
 J. Gotcher, Ph.D.

Please join a conference call with Altairnano's management team for an update on the company's financial results and principal business developments. The conference call dial-in number for both U.S. and international callers is +1.973.582.2706. Please dial into the conference five minutes before the call is scheduled to begin and ask the operator for conference number 7689679. An audio replay of the conference call will be available from August 7 through August 14, 2006, and can be accessed by dialing +1.973.341.3080 and entering conference number 7689679.

Additionally, the conference call is being webcast by ViaVid Communications and can be accessed by visiting http://viavid.net/dce.aspx?sid=000033E2 or Altairnano's web site, www.altairnano.com.

ABOUT ALTAIR NANOTECHNOLOGIES INC.

Altairnano is an innovator and supplier of advanced ceramic This article is about ceramic materials. For the fine art, see Ceramic art.

The word ceramic is derived from the Greek word κεραμικός (keramikos).
 nanomaterials. With a skilled team of scientists in its 100,000 square foot facilities who, coupled in collaborative col·lab·o·rate  
intr.v. col·lab·o·rat·ed, col·lab·o·rat·ing, col·lab·o·rates
1. To work together, especially in a joint intellectual effort.

2.
 ventures with industry partners and leading academic centers, have developed a unique portfolio of intellectual property and novel products. These researchers are complemented by a seasoned management team with substantial experience in commercializing innovative, disruptive technologies A new technology that has a serious impact on the status quo and changes the way people have been dealing with something, perhaps for decades. Music CDs all but wiped out the phonograph industry within a few years, and digital cameras are destined to eliminate the film industry. .

Altairnano focuses on nanotechnology applications With nanotechnology, a large set of materials and improved products rely on a change in the physical properties when the feature sizes are shrunk. Nanoparticles for example take advantage of their dramatically increased surface area to volume ratio. Their optical properties, e.g.  to enable new high-growth markets. In alternative energy Altairnano is pioneering new battery materials and systems. The company is applying nanotechnology nanotechnology: see micromechanics.
nanotechnology

Manipulation of atoms, molecules, and materials to form structures on the scale of nanometres (billionths of a metre).
 to the development of drug candidates for humans and animals, coatings materials for implants, and materials for dental dental /den·tal/ (den´t'l) pertaining to a tooth or teeth.

den·tal
adj.
1. Of, relating to, or for the teeth.

2. Of, relating to, or intended for dentistry.
 applications. Its high performance nanomaterials have applications in paints, coatings, and the treatment of water and air. The Altair Hydrochloride hydrochloride /hy·dro·chlo·ride/ (-klor´id) a salt of hydrochloric acid.

hy·dro·chlo·ride
n.
A compound resulting from the reaction of hydrochloric acid with an organic base.
 Pigment pigment, substance that imparts color to other materials. In paint, the pigment is a powdered substance which, when mixed in the liquid vehicle, imparts color to a painted surface.  process, the first new patented pigment process in 50 years, is an environmentally friendly Environmentally friendly, also referred to as nature friendly, is a term used to refer to goods and services considered to inflict minimal harm on the environment.[1]  method for manufacturing white pigment used in paints, paper and plastic. For additional information visit www.altairnano.com.

Forward-Looking Statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance Accordance is Bible Study Software for Macintosh developed by OakTree Software, Inc.[]

As well as a standalone program, it is the base software packaged by Zondervan in their Bible Study suites for Macintosh.
 with the "safe harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995, may involve risks, uncertainties and other factors that may cause the company's actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that Altairnano's cash and non-cash expenses Noun 1. non-cash expense - an expense (such as depreciation) that is not paid for in cash
disbursal, disbursement, expense - amounts paid for goods and services that may be currently tax deductible (as opposed to capital expenditures)
 will rise significantly during the following year as a result of unforeseen events; that in future testing and/or and/or  
conj.
Used to indicate that either or both of the items connected by it are involved.

Usage Note: And/or is widely used in legal and business writing.
 commercial use, the various Altairnano products and potential products referenced in this release may not demonstrate expected results or may not prove competitive with existing products or products under development; that, irrespective of irrespective of
prep.
Without consideration of; regardless of.

irrespective of
preposition despite 
 a product's potential, parties to our development and license agreements may abandon abandon v. to intentionally and permanently give up, surrender, leave, desert, or relinquish all interest or ownership in property, a home or other premises, a right of way, and even a spouse, family, or children.  commercialization or marketing efforts for various internal reasons; that applications for key patents may be denied or key regulatory reg·u·late  
tr.v. reg·u·lat·ed, reg·u·lat·ing, reg·u·lates
1. To control or direct according to rule, principle, or law.

2.
 approvals may not be obtained for technical or other reasons; and that even if full commercialization occurs, sales may not reach expected levels for one or more reasons, including failure of the product to perform as expected, the introduction of a superior product or the withdrawal from the project of key commercial partners. In general, Altairnano is, and expects to be in the immediate future, dependent upon funds generated from sales of securities, grants, testing agreements, and licensing agreements to fund its testing, development and ongoing operations. In addition, other risks are identified in the company's most recent Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 and Form 10-Q Form 10-Q

See 10-Q.
, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.
ALTAIR NANOTECHNOLOGIES INC. AND SUBSIDIARIES
                     CONSOLIDATED BALANCE SHEETS
                 (Expressed in United States Dollars)
                             (Unaudited)

                                              June 30,    December 31,
                                                2006          2005
                                            ------------  ------------
                  ASSETS
Current Assets
   Cash and cash equivalents               $  1,678,372  $  2,264,418
   Investment in available for sale
    securities                               12,764,844    20,789,656
   Accounts receivable                          474,446       602,168
   Prepaid expenses and other current
    assets                                      392,076       254,067
                                            ------------  ------------
          Total current assets               15,309,738    23,910,309

Investment in Available for Sale Securities     906,124       423,000

Property, Plant and Equipment, net            9,902,278     8,169,445

Patents, net                                    847,655       890,062

Other Assets                                     21,261        71,200
                                            ------------  ------------

               Total Assets                $ 26,987,056  $ 33,464,016
                                            ============  ============

   LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
   Trade accounts payable                  $  1,792,032  $    808,905
   Accrued salaries and benefits                920,844       709,349
   Accrued liabilities                          467,969       309,289
   Note payable, current portion                600,000       600,000
                                            ------------  ------------
          Total current liabilities           3,780,845     2,427,543
                                            ------------  ------------

Note Payable, Long-Term Portion               1,800,000     2,400,000
                                            ------------  ------------

Stockholders' Equity
   Common stock, no par value, unlimited
    shares authorized; 59,461,393 and
    59,316,519 shares issued and
    outstanding at June 30, 2006 and
    December 31, 2005                        92,232,886    92,126,714
   Additional paid in capital                   877,512             -
   Accumulated deficit                      (71,501,987)  (63,152,905)
   Deferred compensation expense                      -      (165,336)
   Accumulated other comprehensive loss        (202,200)     (172,000)
                                            ------------  ------------

        Total Stockholders' Equity           21,406,211    28,636,473
                                            ------------  ------------

Total Liabilities and Stockholders' Equity $ 26,987,056  $ 33,464,016
                                            ============  ============




            ALTAIR NANOTECHNOLOGIES INC. AND SUBSIDIARIES
                CONSOLIDATED STATEMENTS OF OPERATIONS
                 (Expressed in United States Dollars)
                             (Unaudited)

                      Three Months Ended        Three Months Ended
                           March 31,                 June 30,
                    ------------------------  ------------------------
                       2006         2005         2006         2005
                    -----------  -----------  -----------  -----------
Revenues
License fees       $         -  $   695,000  $   364,720  $         -
Product sales            8,018       23,108        2,640       42,485
Commercial
 collaborations        330,270       96,266      389,236      160,775
Contracts and
 grants                207,008      213,206      300,232      299,621
                    -----------  -----------  -----------  -----------
Total revenues         545,296    1,027,580    1,056,828      502,881
                    -----------  -----------  -----------  -----------
Operating Expenses
Cost of product
 sales                   1,266        3,546        1,450       12,461
Research and
 development         1,948,387      781,535    2,205,265      744,142
Sales and marketing    393,161      730,438      618,422      190,670
General and
 administrative      2,611,304    1,565,435    1,796,853    1,355,698
Depreciation and
 amortization          316,871      244,630      363,247      251,455
                    -----------  -----------  -----------  -----------
Total operating
 expenses            5,270,989    3,325,584    4,985,237    2,554,426
                    -----------  -----------  -----------  -----------
Loss from
 Operations         (4,725,693)  (2,298,004)  (3,928,409)  (2,051,545)
                    -----------  -----------  -----------  -----------
Other Income
 (Expense)
Interest expense       (45,500)     (50,700)     (42,000)     (51,592)
Interest income        211,303      103,276      181,522      184,383
Loss on foreign
 exchange                 (174)        (531)        (131)        (324)
                    -----------  -----------  -----------  -----------
Total other income,
 net                   165,629       52,045      139,391      132,467
                    -----------  -----------  -----------  -----------

Net Loss           $(4,560,064) $(2,245,959) $(3,789,018) $(1,919,078)
                    ===========  ===========  ===========  ===========

Loss per common
 share - Basic and
 diluted           $     (0.08) $     (0.04) $     (0.06) $     (0.03)
                    ===========  ===========  ===========  ===========

Weighted average
 shares - Basic and
 diluted            59,222,352   54,237,653   59,290,242   58,814,970
                    ===========  ===========  ===========  ===========




                                                  Six Months Ended
                                                      June 30,
                                              ------------------------
                                                 2006         2005
                                              -----------  -----------
Revenues
License fees                                 $   364,720  $   695,000
Product sales                                     10,658       65,593
Commercial collaborations                        719,506      257,041
Contracts and grants                             507,240      512,827
                                              -----------  -----------
Total revenues                                 1,602,124    1,530,461
                                              -----------  -----------
Operating Expenses
Cost of product sales                              2,716       16,007
Research and development                       4,153,652    1,525,677
Sales and marketing                            1,011,583      921,108
General and administrative                     4,408,157    2,921,133
Depreciation and amortization                    680,118      496,085
                                              -----------  -----------
Total operating expenses                      10,256,226    5,880,010
                                              -----------  -----------
Loss from Operations                          (8,654,102)  (4,349,549)
                                              -----------  -----------
Other Income (Expense)
Interest expense                                 (87,500)    (102,292)
Interest income                                  392,825      287,659
Loss on foreign exchange                            (305)        (855)
                                              -----------  -----------
Total other income, net                          305,020      184,512
                                              -----------  -----------

Net Loss                                     $(8,349,082) $(4,165,037)
                                              ===========  ===========

Loss per common share - Basic and diluted    $     (0.14) $     (0.07)
                                              ===========  ===========

Weighted average shares - Basic and diluted   59,256,485   56,524,538
                                              ===========  ===========

COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 7, 2006
Words:1615
Previous Article:Gregg Appliances, Inc. Announces Operating Results Conference Call.
Next Article:Discover(R) Card Survey Provides Comprehensive Look at Consumer Opinions of Customer Service.



Related Articles
EARNINGS SOAR FOR NORTHWEST, CONTINENTAL.
Altair Nanotechnologies Named to Greentech Line-up at ThinkEquity's Annual Growth Conference; Altairnano Will Deliver Featured Presentation on Its...
Altair Nanotechnologies to Demonstrate Advances in NanoSafe(TM) Rechargeable Battery Program at Zero Emission Vehicle Symposium; Safety, Reliability,...
Altairnano Presents at the Lux Executive Summit.
Altair Nanotechnologies Revenues Rise 28 Percent in Third Quarter.
Altair Nanotechnologies Announces Third Quarter Financial Results Conference Call.
Altair Nanotechnologies Appoints AES Executive Robert F. Hemphill to Board of Directors.
Altair Nanotechnologies Announces First Quarter 2007 Financial Results Conference Call.
Altair Nanotechnologies Reports First Quarter 2007 Financial Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles